Review
Nature Reviews Immunology 6, 930-939 (December 2006) | doi:10.1038/nri1959
Progress and obstacles in the development of an AIDS vaccine
Norman L. Letvin1 About the author
Abstract
Recent experimental observations suggest approaches to immunization that might finally result in at least a partially effective vaccine against infection with HIV-1. In particular, advances in our understanding of the contribution of vaccine-elicited cellular immunity to protecting memory CD4+ T cells from virus-mediated destruction provide rational strategies for the development of this vaccine. This is therefore an ideal time to review our current understanding of HIV-1 and its control by the immune system, as well as the remaining problems that must be solved to facilitate the development of an effective vaccine against AIDS.
- View At a Glance
Author affiliations
-
Division of Viral Pathogenesis, Department of Medicine, Beth Israel Deaconess Medical Center, Harvard Medical School, 330 Brookline Avenue, Boston, Massachusetts 02215, USA.
Email: nletvin@bidmc.harvard.edu
MORE ARTICLES LIKE THIS
These links to content published by NPG are automatically generated.
NEWS AND VIEWS
Is an HIV vaccine possible?Nature Medicine News and Views (01 Jun 1999)
CTL to HIV-1: Surrogates or sirensNature Medicine News and Views (01 Apr 1995)
See all 5 matches for News And ViewsRESEARCH
Mucosal AIDS vaccine reduces disease and viral load in gut reservoir and blood after mucosal infection of macaquesNature Medicine Article (01 Dec 2001)
HIV/AIDS Vaccines: 2007Clinical Pharmacology & Therapeutics Article Response
See all 56 matches for Research
